HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 2,024: Line 2,024:
|Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK)
|Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK)
| ||
| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SK|| ||
|Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SK|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SK|| ||
|Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SK|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| ||
|T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Early T-precursor lymphoblastic leukaemia / lymphoma
|Early T-precursor lymphoblastic leukaemia / lymphoma
Line 2,061: Line 2,061:
|
|
|
|
|
|Early T-Cell Precursor Lymphoblastic Leukemia
|Fei Yang, MD, FACMG, Kaiser Permanente Northwest
|Fei Yang, MD, FACMG, Kaiser Permanente Northwest
|
|Pending
|
|
|
|
Line 2,077: Line 2,077:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
|T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
|
|T-cell Large Granular Lymphocytic Leukemia
|*Michelle Don, MD, MS
|Michelle Don, MD, MS
|
|Pending
|
|
|
|
|-
|-
|NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
|NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| ||
|
|Chronic Lymphoproliferative Disorder of NK Cells
|Michelle Don, MD
|Michelle Don, MD
|
|Pending
|
|
|
|
|-
|-
|Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| ||
|Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| ||
|
|Adult T-cell Leukemia/Lymphoma
|Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG  Vanderbilt University Medical Center
|Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG  Vanderbilt University Medical Center
|
|?Pending
|
|
|
|
|-
|-
|Sezary syndrome||Disease|| || || || || ||SK|| ||
|Sezary syndrome||Disease|| || || || || ||SK|| ||
|
|Sézary Syndrome
|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
|Madison E. Hannay, DO, Medical University of South Carolina  Tingting Barrett, MD, Medical University of South Carolina  Daynna J. Wolff, PhD, Medical University of South Carolina
|
|Pending
|
|
|
|
|-
|-
|Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| ||
|Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| ||
|
|Aggressive NK-cell Leukemia
|Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|Shanelle De Lancy, MD, Shashirekha Shetty, PhD
|
|?Pending
|
|
|
|